scholarly journals Low-Resistance, Concentric-Gated Pediatric Artificial Lung for End-Stage Lung Failure

ASAIO Journal ◽  
2020 ◽  
Vol 66 (4) ◽  
pp. 423-432 ◽  
Author(s):  
Alex J. Thompson ◽  
Skylar Buchan ◽  
Benjamin Carr ◽  
Clinton Poling ◽  
McKenzie Hayes ◽  
...  
1994 ◽  
Vol 5 (3) ◽  
pp. 263-277
Author(s):  
Lynne Cipriani ◽  
Sarah A. Martin

Transplantation in children has become a therapeutic option for several end stage organ diseases. The kidney, liver, and heart are the most common organs transplanted; however, an increasing number of children are undergoing successful intestine, lung, and multiple organ transplant combinations. Through case study reports, emerging transplant options for the child experiencing end stage liver, intestine, heart, and lung failure are described. Critical care nurses play a crucial role in the postoperative recovery of these patients. An understanding of the transplant process and consequences of immunosuppression will help the critical care nurse identify signs of rejection, infection, and posttransplant lymphoprolifcrative disease


ASAIO Journal ◽  
2020 ◽  
Vol 66 (5) ◽  
pp. 572-579
Author(s):  
Benjamin D. Carr ◽  
Clinton J. Poling ◽  
Pavel Hala ◽  
Matias Caceres Quinones ◽  
Aaron R. Prater ◽  
...  
Keyword(s):  

2013 ◽  
Vol 145 (6) ◽  
pp. 1660-1666 ◽  
Author(s):  
Christopher N. Scipione ◽  
Rebecca E. Schewe ◽  
Kelly L. Koch ◽  
Andrew W. Shaffer ◽  
Amit Iyengar ◽  
...  

2012 ◽  
Vol 94 (5) ◽  
pp. 1688-1694 ◽  
Author(s):  
Rebecca E. Schewe ◽  
Christopher N. Scipione ◽  
Kelly L. Koch ◽  
Keith E. Cook

1980 ◽  
Vol 3 (3) ◽  
pp. 157-160
Author(s):  
P.M. Galletti

Mechanical systems to oxygenate blood outside of the body were first employed in clinical medicine as a component of the «heart-lung machine». The artificial lung has been an essential component of the technology underlying the progress of cardiovascular surgery since 1950. Its impact on clinical medicine can be measured by the widespread acceptance of cardiac surgery for the treatment first of congenital malformations, then valvular lesions, and more recently, coronary artery disease. Whereas the use of the artificial lung during temporary exclusion of the pulmonary circulation for surgical purposes is now well established, the chronic application of extracorporeal membrane oxygenation in end-stage respiratory failure is still controversial. Internally implantable lung prostheses are still at the conceptual or developmental stage, and are unlikely to impact on clinical medicine for another decade.


2000 ◽  
Vol 69 (2) ◽  
pp. 351-356 ◽  
Author(s):  
William R Lynch ◽  
J.Patrick Montoya ◽  
David O Brant ◽  
Robert J Schreiner ◽  
Mark D Iannettoni ◽  
...  

ASAIO Journal ◽  
2000 ◽  
Vol 46 (2) ◽  
pp. 181 ◽  
Author(s):  
S. D. Lick ◽  
S. K. Alpard ◽  
P. Montoya ◽  
D. J. Deyo ◽  
S. A. Witt ◽  
...  

Author(s):  
Brian P. Fallon ◽  
Alex J. Thompson ◽  
Aaron Prater ◽  
Skylar Buchan ◽  
Trevor Alberts ◽  
...  

Author(s):  
Heather Wanczyk ◽  
Todd Jensen ◽  
Daniel J. Weiss ◽  
Christine Finck

Lung transplantation remains the only viable option for individuals suffering from end-stage lung failure. However, a number of current limitations exist including a continuing shortage of suitable donor lungs and immune rejection following transplantation. To address these concerns, engineering a decellularized biocompatible lung scaffold from cadavers reseeded with autologous lung cells to promote tissue regeneration is being explored. Proof-of-concept transplantation of these bioengineered lungs into animal models has been accomplished. However, these lungs were incompletely recellularized with resulting epithelial and endothelial leakage and insufficient basement membrane integrity. Failure to repopulate lung scaffolds with all of the distinct cell populations necessary for proper function remains a significant hurdle for the progression of current engineering approaches and precludes clinical translation. Advancements in 3D bioprinting, lung organoid models and microfluidic device and bioreactor development have enhanced our knowledge of pulmonary lung development, as well as important cell-cell and cell-matrix interactions, all of which will help in the path to a bioengineered transplantable lung. However, a significant gap in knowledge of the spatiotemporal interactions between cell populations as well as relative quantities and localization within each compartment of the lung necessary for its proper growth and function remains. This review will provide an update on cells currently used for reseeding decellularized scaffolds with outcomes of recent lung engineering attempts. Focus will then be on how data obtained from advanced single cell analyses, coupled with multi-omics approaches and high-resolution 3D imaging, can guide current lung bioengineering efforts for the development of fully functional, transplantable lungs.


ASAIO Journal ◽  
2012 ◽  
Vol 58 (6) ◽  
pp. 583-589 ◽  
Author(s):  
Rebecca E. Schewe ◽  
Khalil M. Khanafer ◽  
Aarthi Arab ◽  
Jeffrey A. Mitchell ◽  
David J. Skoog ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document